News
A research team at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan has succeeded in establishing a model of the blood-brain barrier using modularized tissue derived from human cells.
To assess the barrier integrity ... a better improved model with the blood flow circulation which is the more accurate approach to measure drug [permeability],” he said. “But in terms of neurovascular ...
Working under Andreas Hierlemann, Modena and his colleagues spent three and a half years developing the open-microfluidic 3D blood-brain barrier model. To recreate the barrier, the research team took ...
A 3D model accurately mimicking the Blood-Brain Barrier (BBB) in a laboratory environment has been successfully developed by research teams led by Professor Jinah Jang from the Departments of ...
Pulsante is a minimally invasive pain treatment implant system for delivering modulation beyond the blood brain barrier.
WPI's EVOM™ family of TEER instrumentation has set the standard for barrier function assessment for over 30 years. SynVivo's ...
Now, bioengineers finally believe they’re on the brink of breaching that barrier. And they plan to use it for good. “Our model performed better at crossing the blood-brain barrier than others ...
4mon
News Medical on MSNInnovative 3D blood-brain barrier model enhances understanding of neuroinflammationA 3D model accurately mimicking the Blood-Brain Barrier (BBB) in a laboratory environment has been successfully developed by ...
A new model of the blood-brain barrier has been developed by researchers in Israel and Italy. This discovery may help to conduct various studies that find ways to prevent meningitis in newborns.
"With our new model, the findings provide a simple answer ... % of the variability in the data from drugs that cross the blood-brain barrier by passive diffusion." The study also looked at those ...
How do breast cancer cells bypass the blood-brain barrier (BBB) to colonize the brain? This study uncovers a ...
1d
Pharmaceutical Technology on MSNFDA approves Capsida’s CAP-003 gene therapy for Parkinson’sThe FDA has approved Capsida Biotherapeutics' investigational new drug (IND) application for CAP-003 to treat Parkinson’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results